Table 8. miRNAs significantly different in SER samples from PD vs. PDD and Control vs. AD.
Parkinson's vs Parkinson's with Dementia | Control subjects vs Alzheimer's subjects | ||||
hsa-mirName | FC (log2) | Adjusted p-Value | hsa-mirName | FC (log2) | Adjusted p-Value |
miR-34c-5p | 2.12 | 0.002 | miR-34c-5p | 1.57 | 0.002 |
miR-34b-5p | 2.01 | 0.009 | miR-34b-5p | 1.71 | 0.003 |
miR-375 | −1.61 | 0.008 | miR-375 | −0.94 | 0.033 |
Sample size for serum consisted of PD (n = 322), PDD (n = 188), AD (n = 53) and Control (n = 62) subjects. Results were filtered at corrected p-value <0.05. The logarithmic base 2 fold change (FC) is relative to the first listed group for each comparison. P-Values are adjusted for multiple corrections.